Novartis Bioventures Ltd, 10% Owner at AILERON THERAPEUTICS INC (ALRN), sold 323,076 shares at $2.12 ($673K) on 2019-03-13, disclosed to the SEC on 2019-03-15.
Open-market sale of $673k ALRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.12 | 132,738 | $281K | 41.8% |
| 2 | $2.12 | 132,738 | $281K | 41.8% |
| 3 | $1.88 | 13,800 | $26K | 3.9% |
| 4 | $1.92 | 43,800 | $84K | 12.5% |
| Total | $2.08 avg | 323,076 | $673K | 100% |
| Filing → |
| GRTX | SELL | 2020-06-04 | $251K | — | Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |